InvestorsHub Logo
Followers 22
Posts 1898
Boards Moderated 0
Alias Born 07/18/2019

Re: Nistel post# 64126

Tuesday, 11/24/2020 3:17:41 PM

Tuesday, November 24, 2020 3:17:41 PM

Post# of 70694
Chairman Richard Hylen stated, “Currently our subsidiary Proscere Bioscience has completed its testing and will move forward with manufacturing the pending extraction systems and initial $20M in orders; we are now contracted to manufacture systems for a company based in Northern California that services the cannabis grower on the west coast. We are anticipating 3rd quarter revenues of $3M that will demonstrate our projectile of $200M over the next 5 years. We have a new team of cannabis experts and technology that will allow our company to benefit in revenue growth for our shareholders.” ................... WHERE IS THE 3 million in the 3rd quarter that supposed to demonstrate their projectile of 200 million ?????